Key terms

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest JAZZ news

Apr 08 10:00pm ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE), Sarepta Therapeutics (SRPT) and Jazz Pharmaceuticals (JAZZ) by TipRanks Apr 02 7:34am ET Jazz completes rolling submission of BLA for zanidatamab antibody by TipRanks Mar 24 9:50pm ET Analysts Are Bullish on Top Healthcare Stocks: Immatics (IMTX), Vor Biopharma (VOR) by TipRanks Mar 21 2:20am ET Optimistic Outlook on Jazz Pharmaceuticals’ Zanidatamab Across Multiple Cancer Types: A Buy Rating Analysis by TipRanks Mar 20 7:21am ET Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Clene (CLNN) and Jazz Pharmaceuticals (JAZZ) by TipRanks Mar 20 7:17am ET Truist Financial Remains a Buy on Jazz Pharmaceuticals (JAZZ) by TipRanks Mar 20 6:58am ET Jazz Pharmaceuticals price target raised to $188 from $171 at Piper Sandler by TipRanks Mar 20 6:45am ET Buy Rating Affirmed for Jazz Pharmaceuticals on Strong Zanidatamab Revenue Prospects and Clinical Milestones by TipRanks Mar 20 6:10am ET Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Jazz Pharmaceuticals (JAZZ) by TipRanks Mar 20 5:10am ET Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Shockwave Medical (SWAV) and Healthequity (HQY) by TipRanks Mar 15 9:22am ET Jazz Pharmaceuticals price target raised to $230 from $225 at Stifel by TipRanks Mar 14 6:20am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurocrine (NBIX), Jazz Pharmaceuticals (JAZZ) and scPharmaceuticals (SCPH) by TipRanks Mar 12 6:25am ET Zymeworks price target raised to $14 from $12 at Wells Fargo by TipRanks Mar 07 7:15am ET TD Cowen Remains a Buy on Jazz Pharmaceuticals (JAZZ) by TipRanks Mar 05 8:30am ET Avadel Pharmaceuticals price target raised to $22 from $20 at Needham by TipRanks Mar 05 8:28am ET Avadel Pharmaceuticals price target raised to $22 from $20 at Craig-Hallum by TipRanks Mar 05 7:41am ET Avadel Pharmaceuticals price target raised to $29 from $27 at Oppenheimer by TipRanks Mar 04 3:41pm ET Avadel Pharmaceuticals ‘pleased’ with ruling in patent litigation with Jazz Pharmaceuticals by TipRanks Mar 04 3:12pm ET Avadel volatility attributed to ruling in patent fight with Jazz Pharmaceuticals by TipRanks Mar 04 12:20am ET 5 Best Biotech Stocks to Buy Now, According to Analysts – March 2024 by TipRanks Mar 01 5:39am ET Jazz Pharmaceuticals price target lowered to $230 from $235 at Barclays by TipRanks Mar 01 5:04am ET Analysts Offer Insights on Healthcare Companies: Penumbra (PEN), Jazz Pharmaceuticals (JAZZ) and Argenx Se (ARGX) by TipRanks Mar 01 3:00am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Puma Biotechnology (PBYI) and MoonLake Immunotherapeutics (MLTX) by TipRanks Mar 01 1:12am ET Jazz Pharmaceuticals: A Buy Rating Backed by Solid Growth Prospects and Strong Pipeline by TipRanks Mar 01 1:10am ET Analysts Are Bullish on Top Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Oculis Holding (OCS) by TipRanks Feb 29 8:53am ET Jazz Pharmaceuticals price target lowered to $220 from $225 at Needham by TipRanks Feb 29 8:20am ET Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Jazz Pharmaceuticals (JAZZ) and Cooper Co (COO) by TipRanks Feb 29 7:50am ET Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Jazz Pharmaceuticals (JAZZ) and Natera (NTRA) by TipRanks Feb 29 7:48am ET Jazz Pharmaceuticals price target lowered to $173 from $184 at BofA by TipRanks Feb 29 7:31am ET Analysts Are Bullish on These Healthcare Stocks: Addus Homecare (ADUS), Jazz Pharmaceuticals (JAZZ) by TipRanks Feb 29 7:20am ET Jazz Pharmaceuticals (JAZZ) Receives a Rating Update from a Top Analyst by TipRanks

No recent news articles are available for JAZZ

Mar 28 10:15am ET Cancer and the Combination Approach by Accesswire Mar 20 10:15am ET Jazz Pharmaceuticals Celebrates International Women’s Day by Accesswire Mar 14 12:00pm ET Exploring How Jazz Pharmaceuticals Honored U.S. Black History Month by Accesswire

JAZZ Financials

1-year income & revenue

Key terms

JAZZ Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

JAZZ Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel
JPMorgan beat earnings expectations this Friday, unofficially kicking off the first quarter earnings season.
Win McNamee/Getty Images
Jamie Dimon says chance of a bad economy is ‘higher than other people think’